Maxim downgraded Quince Therapeutics (QNCX) to Hold from Buy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNCX:
- Spotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
- Vanguard VTI Daily Snapshot — Jan. 30
- Quince Therapeutics downgraded to Hold from Buy at D. Boral Capital
- Citizens downgrades Quince Therapeutics on study failure
- Quince Therapeutics downgraded to Market Perform from Outperform at Citizens